- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Dr Julie M. Vose to Discuss Value, Quality, and Cost in AJMC Tweetchat
On November 3, at 11 a.m. EST, the president of the American Society of Clinical Oncology will host a tweetchat with The American Journal of Managed Care. Get a preview of Dr. Julie Vose's speech at Patient-Centered Oncology Care.
FOR IMMEDIATE RELEASEOctober 30, 2015
PLAINSBORO, N.J.—On November 19, Julie M. Vose, MD, MBA, FASCO, current president of the American Society of Clinical Oncology (ASCO), will give a keynote address at this year’s Patient-Centered Oncology Care meeting in Baltimore, Maryland, but Twitter users will get a free preview 2 weeks earlier.
During a tweetchat from 11-11:45 am EST on November 3, The American Journal of Managed Care (AJMC) will host a tweetchat with ASCO, where Dr Vose will preview her speech, which will focus on what it will take to ensure true patient-centered oncology care.
ASCO’s president will also answer questions from participants and discuss topics that include evidence-based practice, rapid learning systems, and driving high-quality, high-value cancer care in a post-sustainable growth rate world.
“This is a time of great challenge and great opportunity for cancer care,” said Dr Vose. “Having a dialogue with all stakeholders is so important to ensure our patients remain the primary focus during a period of tremendous change.”
AJMC and ASCO encourage Twitter users to submit questions and participate in the chat on Tuesday, November 3, by using #AJMCchat. And don’t forget to follow @AJMC_Journal, @ASCO, and @DrJulieVose.
There is still time to register for Patient-Centered Oncology Care to see Dr Vose give her keynote speech and attend sessions on genomics in oncology, the future of immuno-oncology, innovations for patient-centered care, and accountable care in oncology with speakers such as Peter Bach, MD, MPP; Michael A. Kolodziej, MD; Ted Okon, MBA; Debra Patt, MD, MPH, MBA; and Yousuf Zafar, MD, MHS. Learn more about the meeting and register now.
About the Journals
The American Journal of Managed Care celebrates its 20th year in 2015 as the leading peer-reviewed journal dedicated to issues in managed care. Other titles in the franchise include The American Journal of Pharmacy Benefits, which provides pharmacy and formulary decision-makers with information to improve the efficiency and health outcomes in managing pharmaceutical care, and The American Journal of Accountable Care, which publishes research and commentary on innovative healthcare delivery models facilitated by the 2010 Affordable Care Act. AJMC’s Evidence-Based series brings together stakeholder views from payers, providers, policymakers and pharmaceutical leaders in oncology and diabetes management. To order reprints of articles appearing in AJMC publications, please call (609) 716-7777, x 131.
About American Society of Clinical Oncology
Founded in 1964, the American Society of Clinical Oncology (ASCO) is the world’s leading professional organization representing physicians who care for people with cancer. With more than 35,000 members, ASCO is committed to improving cancer care through scientific meetings, educational programs, and peer-reviewed journals. ASCO is supported by its affiliate organization, the Conquer Cancer Foundation, which funds ground-breaking research and programs that make a tangible difference in the lives of people with cancer. For ASCO information and resources, visit www.asco.org. Patient-oriented cancer information is available at www.cancer.net. For cancer-related policy developments, please visit ascoaction.asco.org.
CONTACT: Nicole Beagin (609) 716-7777 x 131
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Oncology Onward: A Conversation With Penn Medicine's Dr Justin Bekelman
December 19th 2023Justin Bekelman, MD, director of the Penn Center for Cancer Care Innovation, sat with our hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, for our final episode of 2023 to discuss the importance of collaboration between academic medicine and community oncology and testing innovative cancer care delivery in these settings.
Listen
